Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-08-03

FDA Approved: ESCITALOPRAM OXALATE — Supplemental Application (Camber Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved Camber Pharmaceuticals' supplemental application for escitalopram oxalate, a generic antidepressant product. This constitutes a supplemental approv…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Escitalopram Oxalate (escitalopram oxalate)

Snippet

SUPPL AP for ESCITALOPRAM OXALATE (ESCITALOPRAM OXALATE)